Single Dose Preemptive Plerixafor for Stem Cell Mobilization for ASCT After Lenalidomide Based Therapy in Multiple Myeloma: Impact in Resource Limited Setting
Crossref DOI link: https://doi.org/10.1007/s12288-017-0798-8
Published Online: 2017-03-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumar, Rajiv
Kapoor, Rajan
Asthana, Bhushan
Singh, Jasjit
Verma, Tarun
Chilaka, Rajesh
Singh, N. K.
Sharma, Ajay
Das, S.
Nair, Velu
License valid from 2017-03-03